Mieko Toyoda

Title(s)Adjunct Professor, Pediatrics
SchoolMedicine
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia. Clin Infect Dis. 2020 12 15; 71(12):3168-3173. Jordan SC, Zakowski P, Tran HP, Smith EA, Gaultier C, Marks G, Zabner R, Lowenstein H, Oft J, Bluen B, Le C, Shane R, Ammerman N, Vo A, Chen P, Kumar S, Toyoda M, Ge S, Huang E. PMID: 32575124.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    2. Interleukin-6: An Important Mediator of Allograft Injury. Transplantation. 2020 12; 104(12):2497-2506. Jordan SC, Ammerman N, Choi J, Kumar S, Huang E, Toyoda M, Kim I, Wu G, Vo A. PMID: 32235253.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    3. Imlifidase Inhibits HLA Antibody-mediated NK Cell Activation and Antibody-dependent Cell-mediated Cytotoxicity (ADCC) In Vitro. Transplantation. 2020 08; 104(8):1574-1579. Ge S, Chu M, Choi J, Louie S, Vo A, Jordan SC, Toyoda M. PMID: 32732834.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    4. The role of novel therapeutic approaches for prevention of allosensitization and antibody-mediated rejection. Am J Transplant. 2020 06; 20 Suppl 4:42-56. Jordan SC, Ammerman N, Choi J, Huang E, Peng A, Sethi S, Najjar R, Kim I, Toyoda M, Kumar S, Lim K, Vo A. PMID: 32538536.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    5. Impact of Tocilizumab (Anti-IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients With Chronic Antibody-mediated Rejection. Transplantation. 2020 04; 104(4):856-863. Shin BH, Everly MJ, Zhang H, Choi J, Vo A, Zhang X, Huang E, Jordan SC, Toyoda M. PMID: 31385933.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    6. Novel Therapeutic Approaches to Allosensitization and Antibody-mediated Rejection. Transplantation. 2019 02; 103(2):262-272. Jordan SC, Ammerman N, Choi J, Huang E, Peng A, Sethi S, Najjar R, Toyoda M, Lim K, Louie S, Vo A. PMID: 30247320.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    7. Plasma Exosomes From HLA-Sensitized Kidney Transplant Recipients Contain mRNA Transcripts Which Predict Development of Antibody-Mediated Rejection. Transplantation. 2017 10; 101(10):2419-2428. Zhang H, Huang E, Kahwaji J, Nast CC, Li P, Mirocha J, Thomas DL, Ge S, Vo AA, Jordan SC, Toyoda M. PMID: 28557957.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    8. IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation. N Engl J Med. 2017 08 03; 377(5):442-453. Jordan SC, Lorant T, Choi J, Kjellman C, Winstedt L, Bengtsson M, Zhang X, Eich T, Toyoda M, Eriksson BM, Ge S, Peng A, Järnum S, Wood KJ, Lundgren T, Wennberg L, Bäckman L, Larsson E, Villicana R, Kahwaji J, Louie S, Kang A, Haas M, Nast C, Vo A, Tufveson G. PMID: 28767349.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    9. Cytomegalovirus Immunity After Alemtuzumab Induction in Desensitized Kidney Transplant Patients. Transplantation. 2017 07; 101(7):1720-1726. Ge S, Karasyov A, Sinha A, Petrosyan A, Lovato D, Thomas DL, Vo A, Jordan SC, Toyoda M. PMID: 27841845.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    10. Safety and Efficacy of Alemtuzumab Induction in Highly Sensitized Pediatric Renal Transplant Recipients. Transplantation. 2017 04; 101(4):883-889. Kim IK, Choi J, Vo AA, Kang A, Patel M, Toyoda M, Mirocha J, Kamil ES, Cohen JL, Louie S, Galera O, Jordan SC, Puliyanda DP. PMID: 27495773.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    11. Tocilizumab (Anti-IL-6R) Suppressed TNFa Production by Human Monocytes in an In Vitro Model of Anti-HLA Antibody-Induced Antibody-Dependent Cellular Cytotoxicity. Transplant Direct. 2017 Mar; 3(3):e139. Shin BH, Ge S, Mirocha J, Jordan SC, Toyoda M. PMID: 28361123.
      View in: PubMed   Mentions:
    12. Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients. J Immunol Res. 2017; 2017:5672523. Toyoda M, Shin BH, Ge S, Mirocha J, Thomas D, Chu M, Rodriguez E, Chao C, Petrosyan A, Galera OA, Vo A, Choi J, Peng A, Kahwaji J, Jordan SC. PMID: 28265581.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    13. Desensitization: Overcoming the Immunologic Barriers to Transplantation. J Immunol Res. 2017; 2017:6804678. Sethi S, Choi J, Toyoda M, Vo A, Peng A, Jordan SC. PMID: 28127571.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    14. Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection: Therapeutic Implications of IL-6 Receptor Blockade. Transplantation. 2017 Jan; 101(1):32-44. Jordan SC, Choi J, Kim I, Wu G, Toyoda M, Shin B, Vo A. PMID: 27547870.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansAnimalsCells
    15. A Phase I/II Trial of the Interleukin-6 Receptor-Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize Patients. Transplantation. 2015 Nov; 99(11):2356-63. Vo AA, Choi J, Kim I, Louie S, Cisneros K, Kahwaji J, Toyoda M, Ge S, Haas M, Puliyanda D, Reinsmoen N, Peng A, Villicana R, Jordan SC. PMID: 26018350.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    16. A phase I/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients. Transplantation. 2015 Feb; 99(2):299-308. Vo AA, Zeevi A, Choi J, Cisneros K, Toyoda M, Kahwaji J, Peng A, Villicana R, Puliyanda D, Reinsmoen N, Haas M, Jordan SC. PMID: 25606785.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCTClinical Trials
    17. Genes associated with antibody-dependent cell activation are overexpressed in renal biopsies from patients with antibody-mediated rejection. Transpl Immunol. 2015 Jan; 32(1):9-17. Suviolahti E, Ge S, Nast CC, Mirocha J, Karasyov A, White M, Jordan SC, Toyoda M. PMID: 25449536.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    18. Benefits of rituximab combined with intravenous immunoglobulin for desensitization in kidney transplant recipients. Transplantation. 2014 Aug 15; 98(3):312-9. Vo AA, Choi J, Cisneros K, Reinsmoen N, Haas M, Ge S, Toyoda M, Kahwaji J, Peng A, Villicana R, Jordan SC. PMID: 24770617.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    19. The authors' reply. Transplantation. 2014 Jul 27; 98(2):e8-9. Kahwaji J, Jordan S, Puliyanda D, Toyoda M. PMID: 25022239.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    20. Polyomavirus BK viremia in kidney transplant recipients after desensitization with IVIG and rituximab. Transplantation. 2014 Apr 15; 97(7):755-61. Barbosa D, Kahwaji J, Puliyanda D, Mirocha J, Reinsmoen N, Lai CH, Villicana R, Peng A, Jordan SC, Vo A, Toyoda M. PMID: 24686425.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    21. Regulation of anti-HLA antibody-dependent natural killer cell activation by immunosuppressive agents. Transplantation. 2014 Feb 15; 97(3):294-300. Shin BH, Ge S, Mirocha J, Karasyov A, Vo A, Jordan SC, Toyoda M. PMID: 24342979.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    22. Significant reduction of ATP production in PHA-activated CD4+ cells in 1-day-old blood from transplant patients. Transplantation. 2012 Dec 27; 94(12):1243-9. Suviolahti E, Petrosyan A, Mirocha J, Ge S, Karasyov A, Thomas D, Galera O, Lim W, Jimenez AM, Czer LS, Chaux G, De Leon J, Pao A, Jordan SC, Toyoda M. PMID: 23135604.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsCTClinical Trials
    23. Infectious complications in kidney-transplant recipients desensitized with rituximab and intravenous immunoglobulin. Clin J Am Soc Nephrol. 2011 Dec; 6(12):2894-900. Kahwaji J, Sinha A, Toyoda M, Ge S, Reinsmoen N, Cao K, Lai CH, Villicana R, Peng A, Jordan S, Vo A. PMID: 22157713.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    24. IFN? production by NK cells from HLA-sensitized patients after in vitro exposure to allo-antigens. Transpl Immunol. 2012 Mar; 26(2-3):107-12. Toyoda M, Ge S, Suviolahti E, Pichurin P, Shin B, Pao A, Vo A, Deer N, Aguiluz A, Karasyov A, Jordan SC. PMID: 22101306.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsCTClinical Trials
    25. B-cell immunotherapeutics: emerging roles in solid organ transplantation. Curr Opin Organ Transplant. 2011 Aug; 16(4):416-24. Jordan SC, Kahwaji J, Toyoda M, Vo A. PMID: 21666479.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    26. Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation. Expert Rev Clin Immunol. 2011 May; 7(3):341-8. Jordan SC, Toyoda M, Vo AA. PMID: 21595600.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    27. Immunologic parameters and viral infections in patients desensitized with intravenous immunoglobulin and rituximab. Transpl Immunol. 2011 Apr 15; 24(3):142-8. Ge S, Pao A, Vo A, Deer N, Karasyov A, Petrosyan A, Kahwaji J, Lukovsky M, Chai NN, Aguiluz A, Mirocha J, Jordan SC, Toyoda M. PMID: 21122815.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    28. Development of a real-time quantitative PCR assay for detection of a stable genomic region of BK virus. Virol J. 2010 Oct 29; 7:295. Iwaki KK, Qazi SH, Garcia-Gomez J, Zeng D, Matsuda Y, Matsuda K, Martinez ME, Toyoda M, Kore A, Stevens WT, Smogorzewski M, Iwaki DD, Qazi Y, Iwaki Y. PMID: 21034442.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    29. In vitro effects of everolimus and intravenous immunoglobulin on cell proliferation and apoptosis induction in the mixed lymphocyte reaction. Transpl Immunol. 2010 Aug; 23(4):170-3. Amet N, Gacad M, Petrosyan A, Pao A, Jordan SC, Toyoda M. PMID: 20609387.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    30. Cellular allo reactivity against paternal HLA antigens in normal multiparous females as detected by intracellular cytokine flow cytometry remains elevated over years despite diminution of anti-HLA antibody levels. Transpl Immunol. 2010 Jul; 23(3):133-40. Toyoda M, Ge S, Pao A, Vo A, Deer N, Aguiluz A, Karasyov A, Jordan SC. PMID: 20472061.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsPHPublic Health
    31. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation. Transplantation. 2010 May 15; 89(9):1095-102. Vo AA, Peng A, Toyoda M, Kahwaji J, Cao K, Lai CH, Reinsmoen NL, Villicana R, Jordan SC. PMID: 20110854.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    32. Mycophenolic acid and intravenous immunoglobulin exert an additive effect on cell proliferation and apoptosis in the mixed lymphocyte reaction. Transpl Immunol. 2010 Jul; 23(3):117-20. Sharma KG, Radha R, Pao A, Amet N, Baden L, Jordan SC, Toyoda M. PMID: 20450974.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    33. Advances in diagnosing and managing antibody-mediated rejection. Pediatr Nephrol. 2010 Oct; 25(10):2035-45; quiz 2045-8. Jordan SC, Reinsmoen N, Peng A, Lai CH, Cao K, Villicana R, Toyoda M, Kahwaji J, Vo AA. PMID: 20077121.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    34. Intracellular IFNgamma production in CD3 negative cells exposed to allo-antigens is an indicator of prior sensitization. Transpl Immunol. 2010 Feb; 22(3-4):121-7. Toyoda M, Pao A, Vo A, Lukovsky M, Radha R, Sado T, Ge S, Reinsmoen N, Chai NN, Baden L, Petrosyan A, Skinner E, Mirocha J, Jordan SC. PMID: 19944759.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    35. Intravenous immunoglobulin a natural regulator of immunity and inflammation. Transplantation. 2009 Jul 15; 88(1):1-6. Jordan SC, Toyoda M, Vo AA. PMID: 19584672.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    36. Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med. 2008 Jul 17; 359(3):242-51. Vo AA, Lukovsky M, Toyoda M, Wang J, Reinsmoen NL, Lai CH, Peng A, Villicana R, Jordan SC. PMID: 18635429.
      View in: PubMed   Mentions: 121     Fields:    Translation:HumansCTClinical Trials
    37. Anti-CD20 antibody suppresses anti-HLA antibody formation in a HLA-A2 transgenic mouse model of sensitization. Transpl Immunol. 2008 Jul; 19(3-4):178-86. Wu GD, He Y, Chai NN, Toyoda M, Dunn R, Kehry MR, Klein AS, Jordan SC. PMID: 18595710.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    38. Clinical significance of peripheral blood Epstein-Barr viral load monitoring using polymerase chain reaction in renal transplant recipients. Pediatr Transplant. 2008 Nov; 12(7):778-84. Toyoda M, Moudgil A, Warady BA, Puliyanda DP, Jordan SC. PMID: 18331541.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    39. Outcome of management strategies for BK virus replication in pediatric renal transplant recipients. Pediatr Transplant. 2008 Mar; 12(2):180-6. Puliyanda DP, Toyoda M, Traum AZ, Flores FX, Jordan S, Moudgil A, Somers MJ. PMID: 18307666.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    40. Anti-endothelial cell antibodies are prevalent in juvenile idiopathic arthritis: implications for clinical disease course and pathogenesis. Rheumatol Int. 2007 May; 27(7):655-60. Bloom BJ, Toyoda M, Petrosian A, Jordan S. PMID: 17165085.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    41. Isolated heart and liver transplant recipients are at low risk for polyomavirus BKV nephropathy. Clin Transplant. 2006 May-Jun; 20(3):289-94. Puliyanda DP, Amet N, Dhawan A, Hilo L, Radha RK, Bunnapradist S, Czer L, Martin P, Jordan S, Toyoda M. PMID: 16824143.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    42. Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experience. Clin J Am Soc Nephrol. 2006 Jul; 1(4):844-52. Vo AA, Cam V, Toyoda M, Puliyanda DP, Lukovsky M, Bunnapradist S, Peng A, Yang K, Jordan SC. PMID: 17699296.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    43. Adenovirus mediated IL-10 gene transfer to the airway of the rat lung for prevention of lung allograft rejection. Transpl Immunol. 2006 Aug; 16(2):95-8. Okada Y, Zuo XJ, Toyoda M, Marchevsky A, Matloff JM, Oishi H, Kondo T, Jordan SC. PMID: 16860711.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    44. Co-infection of polyomavirus-BK and cytomegalovirus in renal transplant recipients. Transplantation. 2005 Jul 27; 80(2):198-205. Toyoda M, Puliyanda DP, Amet N, Baden L, Cam V, Radha R, Pao A, Vo A, Bunnapradist S, Moudgil A, Jordan SC. PMID: 16041264.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    45. Current approaches to treatment of antibody-mediated rejection. Pediatr Transplant. 2005 Jun; 9(3):408-15. Jordan SC, Vo AA, Tyan D, Nast CC, Toyoda M. PMID: 15910400.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    46. Post-transplant therapy with high-dose intravenous gammaglobulin: Applications to treatment of antibody-mediated rejection. Pediatr Transplant. 2005 Apr; 9(2):155-61. Jordan SC, Vo AA, Toyoda M, Tyan D, Nast CC. PMID: 15787786.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    47. Cellular immune responses to cytomegalovirus in renal transplant recipients. Am J Transplant. 2005 Jan; 5(1):110-7. Radha R, Jordan S, Puliyanda D, Bunnapradist S, Petrosyan A, Amet N, Toyoda M. PMID: 15636618.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    48. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. J Am Soc Nephrol. 2004 Dec; 15(12):3256-62. Jordan SC, Tyan D, Stablein D, McIntosh M, Rose S, Vo A, Toyoda M, Davis C, Shapiro R, Adey D, Milliner D, Graff R, Steiner R, Ciancio G, Sahney S, Light J. PMID: 15579530.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCTClinical Trials
    49. Immunomodulatory effects of combination of pooled human gammaglobulin and rapamycin on cell proliferation and apoptosis in the mixed lymphocyte reaction. Transplantation. 2004 Oct 27; 78(8):1134-8. Toyoda M, Petrosyan A, Pao A, Jordan SC. PMID: 15502709.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    50. Pooled human gammaglobulin modulates surface molecule expression and induces apoptosis in human B cells. Am J Transplant. 2003 Feb; 3(2):156-66. Toyoda M, Pao A, Petrosian A, Jordan SC. PMID: 12603211.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    51. Posttransplantation lymphoproliferative disorder presenting as a unilateral leg mass 10 years after kidney transplantation. Transplantation. 2002 Dec 15; 74(11):1648-51. Bunnapradist S, Vo A, Toyoda M, Alsabeh R, Lockhart C, Puliyanda D, Jordan SC. PMID: 12490805.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    52. Treatment of active cytomegalovirus disease with oral ganciclovir in renal allograft recipients: monitoring efficacy with quantitative cytomegalovirus polymerase chain reaction. Am J Transplant. 2002 Aug; 2(7):671-3. Jordan SC, Vo A, Bunnapradist S, Toyoda M, Kamil E. PMID: 12201370.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    53. Treatment of parvovirus B-19 (PV B-19) infection allows for successful kidney transplantation without disease recurrence. Am J Transplant. 2002 May; 2(5):425-8. Barsoum NR, Bunnapradist S, Mougdil A, Toyoda M, Vo A, Jordan SC. PMID: 12123207.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    Mieko's Networks
    Concepts (236)
    Derived automatically from this person's publications.
    _
    Co-Authors (11)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _